BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Liu Z, Ji K, Li X, Wang C, Ren Z, Liu Y, Chen X, Han X, Meng L, Li L, Li Z. Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:736330. [PMID: 34660697 DOI: 10.3389/fmolb.2021.736330] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Ding J, Zhao W. The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma. Cancer Manag Res 2022;14:2735-48. [PMID: 36133739 DOI: 10.2147/CMAR.S373165] [Reference Citation Analysis]
2 Yu C, Sun C. Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer. Evid Based Complement Alternat Med 2022;2022:6581127. [PMID: 35711497 DOI: 10.1155/2022/6581127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Damm R, Pech M, Cavalli P, Haag F, Gylstorff S, Omari J, Thormann M, Seidensticker R, Ricke J, Seidensticker M, Relja B. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases. J Cancer Res Clin Oncol 2022. [PMID: 35596772 DOI: 10.1007/s00432-022-04041-x] [Reference Citation Analysis]
4 Hauth F, Roberts HJ, Hong TS, Duda DG. Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers. Int J Mol Sci 2022;23:1926. [PMID: 35216045 DOI: 10.3390/ijms23041926] [Reference Citation Analysis]
5 Suresh A, Dhanasekaran R. Implications of genetic heterogeneity in hepatocellular cancer. Advances in Cancer Research 2022. [DOI: 10.1016/bs.acr.2022.01.007] [Reference Citation Analysis]